TN2010000388A1 - BICYCLIC HETEROCYCLIC DERIVATIVES SPIRO-BICYCLIC PYRAZOLO [1,5-a] PYRIMIDINES HETEROCYCLIC BRIDGES OR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF - Google Patents

BICYCLIC HETEROCYCLIC DERIVATIVES SPIRO-BICYCLIC PYRAZOLO [1,5-a] PYRIMIDINES HETEROCYCLIC BRIDGES OR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF

Info

Publication number
TN2010000388A1
TN2010000388A1 TNP2010000388A TN2010000388A TN2010000388A1 TN 2010000388 A1 TN2010000388 A1 TN 2010000388A1 TN P2010000388 A TNP2010000388 A TN P2010000388A TN 2010000388 A TN2010000388 A TN 2010000388A TN 2010000388 A1 TN2010000388 A1 TN 2010000388A1
Authority
TN
Tunisia
Prior art keywords
derivatives
bicyclic
heterocyclic
pyrimidines
spiro
Prior art date
Application number
TNP2010000388A
Other languages
French (fr)
Inventor
Jeremy Ian Levin
Darrin William Hopper
Nancy Torres
Minu Dhanjish Dutia
Dan Maarten Berger
Xiaolun Wang
Grandi Martin Joseph Di
Chunchun Zhang
Alejandro Lee Dunnick
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/035422 external-priority patent/WO2009108838A1/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of TN2010000388A1 publication Critical patent/TN2010000388A1/en

Links

Abstract

Il est décrit des composés de formule A Et leurs sels pharmaceutiquement acceptables, qui inhibent sélectivement l'activité des kinases Raf et sont utiles pour le traitement de troubles à médiation par les kinases Raf.Compounds of formula A and their pharmaceutically acceptable salts are described which selectively inhibit the activity of Raf kinases and are useful for the treatment of Raf kinase-mediated disorders.

TNP2010000388A 2009-02-27 2010-08-20 BICYCLIC HETEROCYCLIC DERIVATIVES SPIRO-BICYCLIC PYRAZOLO [1,5-a] PYRIMIDINES HETEROCYCLIC BRIDGES OR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF TN2010000388A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/035422 WO2009108838A1 (en) 2008-02-29 2009-02-27 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof

Publications (1)

Publication Number Publication Date
TN2010000388A1 true TN2010000388A1 (en) 2011-12-29

Family

ID=55024511

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000388A TN2010000388A1 (en) 2009-02-27 2010-08-20 BICYCLIC HETEROCYCLIC DERIVATIVES SPIRO-BICYCLIC PYRAZOLO [1,5-a] PYRIMIDINES HETEROCYCLIC BRIDGES OR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF

Country Status (1)

Country Link
TN (1) TN2010000388A1 (en)

Similar Documents

Publication Publication Date Title
MA32110B1 (en) Bicyclic bridged heterocyclic derivatives or spiro-bicyclic heterocyclic derivatives of pyrazolo [1,5-a] pyrimidines, processes for their preparation and their uses
JP5957003B2 (en) Mutant selective EGFR inhibitor and use thereof
MA38380A1 (en) Quinazoline inhibitors of activation of mutant forms of epidermal growth receptor (EGFR)
EA200900152A1 (en) PYRROLOTRIAZINKINASE INHIBITORS
NZ602362A (en) Imidazopyridines syk inhibitors
MD3555097T2 (en) Imidazo[4,5-d]pyrrolo[2,3-b]pyridine compounds as inhibitors of Janus kinases
TN2016000227A1 (en) PYRROLO [2,3-D] PYRIMIDINYL, PYRROLO [2,3-B] PYRAZINYL AND PYROLLO [2,3-D] PYRIDINYL ACRYLAMIDES.
EA201000341A1 (en) 2-ANILINOPURIN-8-ONE AS TTK / MPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
ATE424402T1 (en) IMIDAZOPYRIDINE COMPOUNDS
MX2009008953A (en) Spiro substituted compounds as angiogenesis inhibitors.
MX2009009843A (en) Spiro substituted compounds as angiogenesis inhibitors.
MX2010007714A (en) Fused pyridines active as inhibitors of c-met.
MX2012002480A (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer.
SG195085A1 (en) Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
MX2011012353A (en) N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2, 3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS.
MX2009010728A (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors.
MX2010006748A (en) PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS.
EA201290244A1 (en) IMIDAZO [1,2-b] DERIVATIVES OF PYRIDAZIN AND THEIR APPLICATION AS PDE10 INHIBITORS
WO2009003669A3 (en) Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
MX2010003346A (en) Heterocycle-substituted piperazino-dihydrothienopyrimidines.
EA201290878A1 (en) IMIDAZO [1,2-a] DERIVATIVES AND THEIR APPLICATION FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS
NO20072046L (en) Halogen-substituted benzodiazepine derivatives
TN2009000329A1 (en) 2-AMINO-5,7-DIHYDRO-6H-PYRROLO [3,4-d] -PYRIMIDINE DERIVATIVES AS INHBITORS OF HSP-90 FOR THE TREATMENT OF CANCER
CR9622A (en) DERIVATIVES OF PIRAZOLO [3,4-D] AZEPIN AS HISTAMINE ANTAGONISTS H3
MX336332B (en) Kinase inhibitors, prodrug forms thereof and their use in therapy.